[
    {
        "id": 10045,
        "drug_name": "BLINCYTO (blinatumomab)",
        "clinical_trial_id": "NCT02003222",
        "has_trial_insight_page": 0,
        "indication": "B-Cell Acute Lymphoblastic Leukemia (B-All)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-06-21",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/AMGN\/news\/142795",
        "note": "FDA Approval on June 21, 2023.",
        "company_entity_id": 372,
        "company_ticker": "AMGN",
        "company_name": "Amgen Inc.",
        "company_price": "276.5400",
        "company_change": 1.18,
        "company_percent_change": 0.43,
        "company_optionable": 1,
        "company_number_of_shares": 535918901,
        "price_change_sparkline": [
            [
                311.832823699025,
                1706677200
            ],
            [
                322.053272003295,
                1706763600
            ],
            [
                320.693853151174,
                1706850000
            ],
            [
                319.483275779212,
                1707109200
            ],
            [
                313.62884422628,
                1707195600
            ],
            [
                293.584858231498,
                1707282000
            ],
            [
                292.572736166415,
                1707368400
            ],
            [
                288.871544693121,
                1707454800
            ],
            [
                292.155980021969,
                1707714000
            ],
            [
                288.236487711108,
                1707800400
            ],
            [
                287.829654332006,
                1707886800
            ],
            [
                289.07,
                1707973200
            ],
            [
                283.7,
                1708059600
            ],
            [
                283.51,
                1708405200
            ],
            [
                283.46,
                1708491600
            ],
            [
                285.18,
                1708578000
            ],
            [
                289.18,
                1708664400
            ],
            [
                286.37,
                1708923600
            ],
            [
                278.49,
                1709010000
            ],
            [
                277.46,
                1709096400
            ],
            [
                273.83,
                1709182800
            ],
            [
                280.33,
                1709269200
            ],
            [
                279.39,
                1709528400
            ],
            [
                276.65,
                1709614800
            ],
            [
                276.59,
                1709701200
            ],
            [
                272.86,
                1709787600
            ],
            [
                273.75,
                1709874000
            ],
            [
                275.36,
                1710129600
            ],
            [
                276.54,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 10022,
        "drug_name": "Jardiance (empagliflozin) - (DINAMO)",
        "clinical_trial_id": "NCT03429543",
        "has_trial_insight_page": 0,
        "indication": "Pediatric type 2 diabetes",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-06-21",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/LLY\/news\/142865",
        "note": "FDA approved for 10 mg and 25 mg tablets on June 21, 2023.",
        "company_entity_id": 382,
        "company_ticker": "LLY",
        "company_name": "Eli Lilly and Company",
        "company_price": "754.9500",
        "company_change": 20.58,
        "company_percent_change": 2.8,
        "company_optionable": 1,
        "company_number_of_shares": 950164452,
        "price_change_sparkline": [
            [
                644.503643637706,
                1706677200
            ],
            [
                659.298247188938,
                1706763600
            ],
            [
                666.505874560051,
                1706850000
            ],
            [
                704.989812947364,
                1707109200
            ],
            [
                703.821817930162,
                1707195600
            ],
            [
                724.13694493877,
                1707282000
            ],
            [
                734.41929423551,
                1707368400
            ],
            [
                738.891617036422,
                1707454800
            ],
            [
                735.996586651903,
                1707714000
            ],
            [
                741.696801650387,
                1707800400
            ],
            [
                757.31,
                1707886800
            ],
            [
                757.78,
                1707973200
            ],
            [
                782.06,
                1708059600
            ],
            [
                755.66,
                1708405200
            ],
            [
                745.91,
                1708491600
            ],
            [
                769.64,
                1708578000
            ],
            [
                769.54,
                1708664400
            ],
            [
                771.92,
                1708923600
            ],
            [
                765,
                1709010000
            ],
            [
                757.64,
                1709096400
            ],
            [
                753.68,
                1709182800
            ],
            [
                782.12,
                1709269200
            ],
            [
                792.28,
                1709528400
            ],
            [
                777.59,
                1709614800
            ],
            [
                779.77,
                1709701200
            ],
            [
                780.16,
                1709787600
            ],
            [
                762.14,
                1709874000
            ],
            [
                734.37,
                1710129600
            ],
            [
                754.95,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 7557,
        "drug_name": "ELEVIDYS (delandistrogene moxeparvovec-rokl)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Duchenne Muscular Dystrophy",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-06-22",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/SRPT\/news\/143153",
        "note": "FDA acelerated Approval on June 22, 2023.",
        "company_entity_id": 536,
        "company_ticker": "RHHBY",
        "company_name": "Roche Holding AG ADR",
        "company_price": "35.1500",
        "company_change": 0.54,
        "company_percent_change": 1.56,
        "company_optionable": 0,
        "company_number_of_shares": 6389213336,
        "price_change_sparkline": [
            [
                35.14,
                1706677200
            ],
            [
                34.32,
                1706763600
            ],
            [
                33.95,
                1706850000
            ],
            [
                33.16,
                1707109200
            ],
            [
                33.27,
                1707195600
            ],
            [
                32.55,
                1707282000
            ],
            [
                32.1,
                1707368400
            ],
            [
                32.31,
                1707454800
            ],
            [
                32.6,
                1707714000
            ],
            [
                32.13,
                1707800400
            ],
            [
                32.02,
                1707886800
            ],
            [
                32.1,
                1707973200
            ],
            [
                32.28,
                1708059600
            ],
            [
                32.74,
                1708405200
            ],
            [
                32.91,
                1708491600
            ],
            [
                32.49,
                1708578000
            ],
            [
                32.96,
                1708664400
            ],
            [
                32.52,
                1708923600
            ],
            [
                33.03,
                1709010000
            ],
            [
                32.93,
                1709096400
            ],
            [
                32.73,
                1709182800
            ],
            [
                33.08,
                1709269200
            ],
            [
                32.88,
                1709528400
            ],
            [
                33.15,
                1709614800
            ],
            [
                33.47,
                1709701200
            ],
            [
                33.77,
                1709787600
            ],
            [
                33.9,
                1709874000
            ],
            [
                34.61,
                1710129600
            ],
            [
                35.15,
                1710216000
            ]
        ],
        "statuses": [
            {
                "label": "Fast Track Designation (FTD)",
                "abbreviation": "FTD",
                "description": "Fast Track Designation (FTD)",
                "description_html": "<p>Fast Track Designation (FTD)<\/p>\n"
            },
            {
                "label": "Orphan Drug Designation (ODD)",
                "abbreviation": "ODD",
                "description": "Orphan Drug Designation (ODD)",
                "description_html": "<p>Orphan Drug Designation (ODD)<\/p>\n"
            }
        ]
    },
    {
        "id": 7557,
        "drug_name": "ELEVIDYS (delandistrogene moxeparvovec-rokl)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Duchenne Muscular Dystrophy",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-06-22",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/SRPT\/news\/143153",
        "note": "FDA acelerated Approval on June 22, 2023.",
        "company_entity_id": 285,
        "company_ticker": "SRPT",
        "company_name": "Sarepta Therapeutics Inc.",
        "company_price": "122.0000",
        "company_change": 0.42,
        "company_percent_change": 0.35,
        "company_optionable": 1,
        "company_number_of_shares": 93855410,
        "price_change_sparkline": [
            [
                118.99,
                1706677200
            ],
            [
                122.83,
                1706763600
            ],
            [
                121.27,
                1706850000
            ],
            [
                125.55,
                1707109200
            ],
            [
                126.41,
                1707195600
            ],
            [
                126.05,
                1707282000
            ],
            [
                127.38,
                1707368400
            ],
            [
                126.87,
                1707454800
            ],
            [
                127.32,
                1707714000
            ],
            [
                124.19,
                1707800400
            ],
            [
                124.3,
                1707886800
            ],
            [
                124.89,
                1707973200
            ],
            [
                134.61,
                1708059600
            ],
            [
                136.14,
                1708405200
            ],
            [
                132.29,
                1708491600
            ],
            [
                134.78,
                1708578000
            ],
            [
                136.53,
                1708664400
            ],
            [
                137.65,
                1708923600
            ],
            [
                141.53,
                1709010000
            ],
            [
                137.5,
                1709096400
            ],
            [
                127.9,
                1709182800
            ],
            [
                128.67,
                1709269200
            ],
            [
                123.88,
                1709528400
            ],
            [
                122.85,
                1709614800
            ],
            [
                120.31,
                1709701200
            ],
            [
                120.78,
                1709787600
            ],
            [
                124.37,
                1709874000
            ],
            [
                121.58,
                1710129600
            ],
            [
                122,
                1710216000
            ]
        ],
        "statuses": [
            {
                "label": "Fast Track Designation (FTD)",
                "abbreviation": "FTD",
                "description": "Fast Track Designation (FTD)",
                "description_html": "<p>Fast Track Designation (FTD)<\/p>\n"
            },
            {
                "label": "Orphan Drug Designation (ODD)",
                "abbreviation": "ODD",
                "description": "Orphan Drug Designation (ODD)",
                "description_html": "<p>Orphan Drug Designation (ODD)<\/p>\n"
            }
        ]
    },
    {
        "id": 7759,
        "drug_name": "LITFULO (ritlecitinib)",
        "clinical_trial_id": "NCT03732807",
        "has_trial_insight_page": 1,
        "indication": "Alopecia areata",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-06-23",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/PFE\/news\/143331",
        "note": "FDA Approved on June 23, 2023.",
        "company_entity_id": 387,
        "company_ticker": "PFE",
        "company_name": "Pfizer Inc.",
        "company_price": "28.0100",
        "company_change": -0.36,
        "company_percent_change": -1.27,
        "company_optionable": 1,
        "company_number_of_shares": 5646778425,
        "price_change_sparkline": [
            [
                27.08,
                1706677200
            ],
            [
                27.29,
                1706763600
            ],
            [
                26.93,
                1706850000
            ],
            [
                26.57,
                1707109200
            ],
            [
                27.5,
                1707195600
            ],
            [
                27.56,
                1707282000
            ],
            [
                27.57,
                1707368400
            ],
            [
                27.56,
                1707454800
            ],
            [
                27.66,
                1707714000
            ],
            [
                26.97,
                1707800400
            ],
            [
                27.11,
                1707886800
            ],
            [
                27.51,
                1707973200
            ],
            [
                27.62,
                1708059600
            ],
            [
                27.59,
                1708405200
            ],
            [
                27.67,
                1708491600
            ],
            [
                27.55,
                1708578000
            ],
            [
                27.76,
                1708664400
            ],
            [
                27.18,
                1708923600
            ],
            [
                26.89,
                1709010000
            ],
            [
                27.04,
                1709096400
            ],
            [
                26.56,
                1709182800
            ],
            [
                26.59,
                1709269200
            ],
            [
                25.89,
                1709528400
            ],
            [
                26.08,
                1709614800
            ],
            [
                27.19,
                1709701200
            ],
            [
                26.79,
                1709787600
            ],
            [
                27.22,
                1709874000
            ],
            [
                28.37,
                1710129600
            ],
            [
                28.01,
                1710216000
            ]
        ],
        "statuses": [
            {
                "label": "Breakthrough Therapy Designation (BTD)",
                "abbreviation": "BTD",
                "description": "Breakthrough Therapy Designation (BTD)",
                "description_html": "<p>Breakthrough Therapy Designation (BTD)<\/p>\n"
            }
        ]
    },
    {
        "id": 3696,
        "drug_name": "Somatrogon (hGH-CTP)",
        "clinical_trial_id": "NCT02968004",
        "has_trial_insight_page": 0,
        "indication": "Children - growth hormone deficiency",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-06-28",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/PFE\/news\/143984",
        "note": "FDA Approved on June 28, 2023.",
        "company_entity_id": 387,
        "company_ticker": "PFE",
        "company_name": "Pfizer Inc.",
        "company_price": "28.0100",
        "company_change": -0.36,
        "company_percent_change": -1.27,
        "company_optionable": 1,
        "company_number_of_shares": 5646778425,
        "price_change_sparkline": [
            [
                27.08,
                1706677200
            ],
            [
                27.29,
                1706763600
            ],
            [
                26.93,
                1706850000
            ],
            [
                26.57,
                1707109200
            ],
            [
                27.5,
                1707195600
            ],
            [
                27.56,
                1707282000
            ],
            [
                27.57,
                1707368400
            ],
            [
                27.56,
                1707454800
            ],
            [
                27.66,
                1707714000
            ],
            [
                26.97,
                1707800400
            ],
            [
                27.11,
                1707886800
            ],
            [
                27.51,
                1707973200
            ],
            [
                27.62,
                1708059600
            ],
            [
                27.59,
                1708405200
            ],
            [
                27.67,
                1708491600
            ],
            [
                27.55,
                1708578000
            ],
            [
                27.76,
                1708664400
            ],
            [
                27.18,
                1708923600
            ],
            [
                26.89,
                1709010000
            ],
            [
                27.04,
                1709096400
            ],
            [
                26.56,
                1709182800
            ],
            [
                26.59,
                1709269200
            ],
            [
                25.89,
                1709528400
            ],
            [
                26.08,
                1709614800
            ],
            [
                27.19,
                1709701200
            ],
            [
                26.79,
                1709787600
            ],
            [
                27.22,
                1709874000
            ],
            [
                28.37,
                1710129600
            ],
            [
                28.01,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 3696,
        "drug_name": "Somatrogon (hGH-CTP)",
        "clinical_trial_id": "NCT02968004",
        "has_trial_insight_page": 0,
        "indication": "Children - growth hormone deficiency",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-06-28",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/PFE\/news\/143984",
        "note": "FDA Approved on June 28, 2023.",
        "company_entity_id": 231,
        "company_ticker": "OPK",
        "company_name": "Opko Health Inc.",
        "company_price": "0.9279",
        "company_change": -0.010000000000000009,
        "company_percent_change": -1.49,
        "company_optionable": 1,
        "company_number_of_shares": 696991667,
        "price_change_sparkline": [
            [
                1.02,
                1706677200
            ],
            [
                1.01,
                1706763600
            ],
            [
                0.995,
                1706850000
            ],
            [
                0.9725,
                1707109200
            ],
            [
                0.9776,
                1707195600
            ],
            [
                1,
                1707282000
            ],
            [
                1.02,
                1707368400
            ],
            [
                1.05,
                1707454800
            ],
            [
                1.04,
                1707714000
            ],
            [
                1,
                1707800400
            ],
            [
                1.03,
                1707886800
            ],
            [
                1.02,
                1707973200
            ],
            [
                1.01,
                1708059600
            ],
            [
                1.03,
                1708405200
            ],
            [
                1.01,
                1708491600
            ],
            [
                0.9701,
                1708578000
            ],
            [
                0.946,
                1708664400
            ],
            [
                0.9965,
                1708923600
            ],
            [
                1.05,
                1709010000
            ],
            [
                0.9855,
                1709096400
            ],
            [
                1,
                1709182800
            ],
            [
                0.9929,
                1709269200
            ],
            [
                1,
                1709528400
            ],
            [
                0.9349,
                1709614800
            ],
            [
                0.939,
                1709701200
            ],
            [
                0.9513,
                1709787600
            ],
            [
                0.9575,
                1709874000
            ],
            [
                0.94,
                1710129600
            ],
            [
                0.9279,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 3755,
        "drug_name": "SKYCLARYS (omaveloxolone)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Friedreich\u2019s ataxia (FA)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-06-28",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/RETA\/news\/143955",
        "note": "PAS approved June 28, 2023.",
        "company_entity_id": 375,
        "company_ticker": "BIIB",
        "company_name": "Biogen Inc.",
        "company_price": "227.3600",
        "company_change": -2.71,
        "company_percent_change": -1.1800000000000002,
        "company_optionable": 1,
        "company_number_of_shares": 145360798,
        "price_change_sparkline": [
            [
                246.66,
                1706677200
            ],
            [
                247.83,
                1706763600
            ],
            [
                243.72,
                1706850000
            ],
            [
                241.84,
                1707109200
            ],
            [
                245.55,
                1707195600
            ],
            [
                240.54,
                1707282000
            ],
            [
                240.3,
                1707368400
            ],
            [
                240.98,
                1707454800
            ],
            [
                244.74,
                1707714000
            ],
            [
                226.65,
                1707800400
            ],
            [
                220.74,
                1707886800
            ],
            [
                223.35,
                1707973200
            ],
            [
                219.08,
                1708059600
            ],
            [
                219.21,
                1708405200
            ],
            [
                221.11,
                1708491600
            ],
            [
                222.48,
                1708578000
            ],
            [
                223.32,
                1708664400
            ],
            [
                223.71,
                1708923600
            ],
            [
                223.94,
                1709010000
            ],
            [
                221.74,
                1709096400
            ],
            [
                216.99,
                1709182800
            ],
            [
                220.95,
                1709269200
            ],
            [
                221.02,
                1709528400
            ],
            [
                217.23,
                1709614800
            ],
            [
                217.56,
                1709701200
            ],
            [
                219.36,
                1709787600
            ],
            [
                223.24,
                1709874000
            ],
            [
                230.07,
                1710129600
            ],
            [
                227.36,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 7247,
        "drug_name": "MIEBO (perfluorohexyloctane ophthalmic solution)",
        "clinical_trial_id": "NCT04567329",
        "has_trial_insight_page": 0,
        "indication": "Dry Eye Disease Associated With Meibomian Gland Dysfunction",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-06-29",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/BLCO\/news\/140815",
        "note": "Approved on May 18, 2023.",
        "company_entity_id": 574,
        "company_ticker": "BHC",
        "company_name": "Bausch Health Companies Inc.",
        "company_price": "9.1900",
        "company_change": 0.07,
        "company_percent_change": 0.77,
        "company_optionable": 1,
        "company_number_of_shares": 365411953,
        "price_change_sparkline": [
            [
                7.85,
                1706677200
            ],
            [
                7.98,
                1706763600
            ],
            [
                7.92,
                1706850000
            ],
            [
                7.77,
                1707109200
            ],
            [
                8.13,
                1707195600
            ],
            [
                8.12,
                1707282000
            ],
            [
                8.13,
                1707368400
            ],
            [
                8.21,
                1707454800
            ],
            [
                8.38,
                1707714000
            ],
            [
                8.41,
                1707800400
            ],
            [
                8.43,
                1707886800
            ],
            [
                8.49,
                1707973200
            ],
            [
                8.51,
                1708059600
            ],
            [
                8.6,
                1708405200
            ],
            [
                8.67,
                1708491600
            ],
            [
                9.3,
                1708578000
            ],
            [
                9.18,
                1708664400
            ],
            [
                8.99,
                1708923600
            ],
            [
                9.18,
                1709010000
            ],
            [
                9.2,
                1709096400
            ],
            [
                9.39,
                1709182800
            ],
            [
                9.89,
                1709269200
            ],
            [
                9.58,
                1709528400
            ],
            [
                9.56,
                1709614800
            ],
            [
                9.23,
                1709701200
            ],
            [
                9.28,
                1709787600
            ],
            [
                9.23,
                1709874000
            ],
            [
                9.12,
                1710129600
            ],
            [
                9.19,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 7247,
        "drug_name": "MIEBO (perfluorohexyloctane ophthalmic solution)",
        "clinical_trial_id": "NCT04567329",
        "has_trial_insight_page": 0,
        "indication": "Dry Eye Disease Associated With Meibomian Gland Dysfunction",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-06-29",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/BLCO\/news\/140815",
        "note": "Approved on May 18, 2023.",
        "company_entity_id": 1452,
        "company_ticker": "BLCO",
        "company_name": "Bausch + Lomb Corporation",
        "company_price": "16.0900",
        "company_change": -0.31000000000000005,
        "company_percent_change": -1.89,
        "company_optionable": 1,
        "company_number_of_shares": 350992243,
        "price_change_sparkline": [
            [
                14.01,
                1706677200
            ],
            [
                14.09,
                1706763600
            ],
            [
                13.98,
                1706850000
            ],
            [
                13.68,
                1707109200
            ],
            [
                14.3,
                1707195600
            ],
            [
                13.94,
                1707282000
            ],
            [
                13.88,
                1707368400
            ],
            [
                14.04,
                1707454800
            ],
            [
                14.66,
                1707714000
            ],
            [
                14.04,
                1707800400
            ],
            [
                14.29,
                1707886800
            ],
            [
                14.24,
                1707973200
            ],
            [
                14.31,
                1708059600
            ],
            [
                14.59,
                1708405200
            ],
            [
                16.6,
                1708491600
            ],
            [
                17.32,
                1708578000
            ],
            [
                17.6,
                1708664400
            ],
            [
                16.88,
                1708923600
            ],
            [
                17.11,
                1709010000
            ],
            [
                16.85,
                1709096400
            ],
            [
                16.5,
                1709182800
            ],
            [
                16.47,
                1709269200
            ],
            [
                16.54,
                1709528400
            ],
            [
                15.92,
                1709614800
            ],
            [
                16.54,
                1709701200
            ],
            [
                16.49,
                1709787600
            ],
            [
                16.33,
                1709874000
            ],
            [
                16.4,
                1710129600
            ],
            [
                16.09,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 4665,
        "drug_name": "Valoctocogene roxaparvovec (BMN 270)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Hemophilia A",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-06-29",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/BMRN\/news\/144395",
        "note": "Approved June 29, 2023.",
        "company_entity_id": 69,
        "company_ticker": "BMRN",
        "company_name": "BioMarin Pharmaceutical Inc.",
        "company_price": "85.1800",
        "company_change": -0.8200000000000001,
        "company_percent_change": -0.95,
        "company_optionable": 1,
        "company_number_of_shares": 188675622,
        "price_change_sparkline": [
            [
                88.08,
                1706677200
            ],
            [
                88.74,
                1706763600
            ],
            [
                88.11,
                1706850000
            ],
            [
                87.72,
                1707109200
            ],
            [
                89.8,
                1707195600
            ],
            [
                89.66,
                1707282000
            ],
            [
                88.15,
                1707368400
            ],
            [
                88.46,
                1707454800
            ],
            [
                88.18,
                1707714000
            ],
            [
                86.13,
                1707800400
            ],
            [
                86.01,
                1707886800
            ],
            [
                88.3,
                1707973200
            ],
            [
                88.77,
                1708059600
            ],
            [
                88.67,
                1708405200
            ],
            [
                88.54,
                1708491600
            ],
            [
                89.97,
                1708578000
            ],
            [
                91.24,
                1708664400
            ],
            [
                90.1,
                1708923600
            ],
            [
                90.68,
                1709010000
            ],
            [
                88.4,
                1709096400
            ],
            [
                86.28,
                1709182800
            ],
            [
                87.14,
                1709269200
            ],
            [
                87.72,
                1709528400
            ],
            [
                86.02,
                1709614800
            ],
            [
                86.77,
                1709701200
            ],
            [
                85.89,
                1709787600
            ],
            [
                85.95,
                1709874000
            ],
            [
                86,
                1710129600
            ],
            [
                85.18,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 7038,
        "drug_name": "mRNA-1345 - (ConquerRSV)",
        "clinical_trial_id": "NCT04528719",
        "has_trial_insight_page": 1,
        "indication": "Respiratory syncytial virus (RSV) vaccine",
        "label": "BLA Filing",
        "value": "blaFiling",
        "simplified_stage": "phase4",
        "stageid": 12,
        "stage_name": "BLA Filing",
        "date": "2023-07-05",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/MRNA\/news\/144860",
        "note": "BLA rolling submission, noted July 5, 2023.",
        "company_entity_id": 618,
        "company_ticker": "MRNA",
        "company_name": "Moderna Inc.",
        "company_price": "110.4300",
        "company_change": -1.55,
        "company_percent_change": -1.38,
        "company_optionable": 1,
        "company_number_of_shares": 382073208,
        "price_change_sparkline": [
            [
                101.05,
                1706677200
            ],
            [
                99.02,
                1706763600
            ],
            [
                97.5,
                1706850000
            ],
            [
                95.49,
                1707109200
            ],
            [
                100.03,
                1707195600
            ],
            [
                99.3,
                1707282000
            ],
            [
                93.66,
                1707368400
            ],
            [
                87.41,
                1707454800
            ],
            [
                89,
                1707714000
            ],
            [
                85.37,
                1707800400
            ],
            [
                85.95,
                1707886800
            ],
            [
                91.14,
                1707973200
            ],
            [
                88.37,
                1708059600
            ],
            [
                86.99,
                1708405200
            ],
            [
                87.59,
                1708491600
            ],
            [
                99.44,
                1708578000
            ],
            [
                96.46,
                1708664400
            ],
            [
                94.02,
                1708923600
            ],
            [
                96.2,
                1709010000
            ],
            [
                97.48,
                1709096400
            ],
            [
                92.24,
                1709182800
            ],
            [
                95.06,
                1709269200
            ],
            [
                96,
                1709528400
            ],
            [
                95.56,
                1709614800
            ],
            [
                98.1,
                1709701200
            ],
            [
                99.48,
                1709787600
            ],
            [
                103.03,
                1709874000
            ],
            [
                111.98,
                1710129600
            ],
            [
                110.43,
                1710216000
            ]
        ],
        "statuses": [
            {
                "label": "Breakthrough Therapy Designation (BTD)",
                "abbreviation": "BTD",
                "description": "Breakthrough Therapy Designation (BTD)",
                "description_html": "<p>Breakthrough Therapy Designation (BTD)<\/p>\n"
            },
            {
                "label": "Fast Track Designation (FTD)",
                "abbreviation": "FTD",
                "description": "Fast Track Designation (FTD)",
                "description_html": "<p>Fast Track Designation (FTD)<\/p>\n"
            }
        ]
    },
    {
        "id": 9546,
        "drug_name": "LEQEMBI (lecanemab)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Mild cognitive impairment (MCI) due to Alzheimer's disease (AD)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-07-06",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/BIIB\/news\/145301",
        "note": "Traditional approval received July 6, 2023.",
        "company_entity_id": 375,
        "company_ticker": "BIIB",
        "company_name": "Biogen Inc.",
        "company_price": "227.3600",
        "company_change": -2.71,
        "company_percent_change": -1.1800000000000002,
        "company_optionable": 1,
        "company_number_of_shares": 145360798,
        "price_change_sparkline": [
            [
                246.66,
                1706677200
            ],
            [
                247.83,
                1706763600
            ],
            [
                243.72,
                1706850000
            ],
            [
                241.84,
                1707109200
            ],
            [
                245.55,
                1707195600
            ],
            [
                240.54,
                1707282000
            ],
            [
                240.3,
                1707368400
            ],
            [
                240.98,
                1707454800
            ],
            [
                244.74,
                1707714000
            ],
            [
                226.65,
                1707800400
            ],
            [
                220.74,
                1707886800
            ],
            [
                223.35,
                1707973200
            ],
            [
                219.08,
                1708059600
            ],
            [
                219.21,
                1708405200
            ],
            [
                221.11,
                1708491600
            ],
            [
                222.48,
                1708578000
            ],
            [
                223.32,
                1708664400
            ],
            [
                223.71,
                1708923600
            ],
            [
                223.94,
                1709010000
            ],
            [
                221.74,
                1709096400
            ],
            [
                216.99,
                1709182800
            ],
            [
                220.95,
                1709269200
            ],
            [
                221.02,
                1709528400
            ],
            [
                217.23,
                1709614800
            ],
            [
                217.56,
                1709701200
            ],
            [
                219.36,
                1709787600
            ],
            [
                223.24,
                1709874000
            ],
            [
                230.07,
                1710129600
            ],
            [
                227.36,
                1710216000
            ]
        ],
        "statuses": [
            {
                "label": "Breakthrough Therapy Designation (BTD)",
                "abbreviation": "BTD",
                "description": "Breakthrough Therapy Designation (BTD)",
                "description_html": "<p>Breakthrough Therapy Designation (BTD)<\/p>\n"
            }
        ]
    },
    {
        "id": 10308,
        "drug_name": "Veklury (remdesivir)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Covid-19",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-07-14",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/GILD\/news\/146490",
        "note": "Approved July 14, 2023.",
        "company_entity_id": 378,
        "company_ticker": "GILD",
        "company_name": "Gilead Sciences Inc.",
        "company_price": "75.0800",
        "company_change": -0.24,
        "company_percent_change": -0.31999999999999995,
        "company_optionable": 1,
        "company_number_of_shares": 1245774616,
        "price_change_sparkline": [
            [
                78.26,
                1706677200
            ],
            [
                78.16,
                1706763600
            ],
            [
                76.96,
                1706850000
            ],
            [
                76.71,
                1707109200
            ],
            [
                77.72,
                1707195600
            ],
            [
                74.42,
                1707282000
            ],
            [
                73.8,
                1707368400
            ],
            [
                73.67,
                1707454800
            ],
            [
                74.45,
                1707714000
            ],
            [
                73.53,
                1707800400
            ],
            [
                73.04,
                1707886800
            ],
            [
                73.37,
                1707973200
            ],
            [
                71.58,
                1708059600
            ],
            [
                72.04,
                1708405200
            ],
            [
                73.2,
                1708491600
            ],
            [
                72.78,
                1708578000
            ],
            [
                73.55,
                1708664400
            ],
            [
                72.95,
                1708923600
            ],
            [
                73.02,
                1709010000
            ],
            [
                72.7,
                1709096400
            ],
            [
                72.1,
                1709182800
            ],
            [
                72.31,
                1709269200
            ],
            [
                72.25,
                1709528400
            ],
            [
                72.99,
                1709614800
            ],
            [
                72.63,
                1709701200
            ],
            [
                73.66,
                1709787600
            ],
            [
                75.12,
                1709874000
            ],
            [
                75.32,
                1710129600
            ],
            [
                75.08,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 7492,
        "drug_name": "Beyfortus (Nirsevimab)",
        "clinical_trial_id": "NCT03979313",
        "has_trial_insight_page": 1,
        "indication": "Respiratory syncytial virus",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-07-17",
        "link": "https:\/\/www.astrazeneca.com\/media-centre\/press-releases\/2023\/beyfortus-approved-in-the-us-for-the-prevention-of-rsv-lower-respiratory-tract-disease-in-infants.html",
        "note": "FDA Approved on July 17, 2023.",
        "company_entity_id": 374,
        "company_ticker": "AZN",
        "company_name": "AstraZeneca PLC",
        "company_price": "67.4000",
        "company_change": -0.27,
        "company_percent_change": -0.4,
        "company_optionable": 1,
        "company_number_of_shares": 3100378676,
        "price_change_sparkline": [
            [
                65.6319311986485,
                1706677200
            ],
            [
                65.8387545112493,
                1706763600
            ],
            [
                64.647058281502,
                1706850000
            ],
            [
                64.1546218229287,
                1707109200
            ],
            [
                66.0258803655072,
                1707195600
            ],
            [
                65.5432926361053,
                1707282000
            ],
            [
                62.5591276971512,
                1707368400
            ],
            [
                61.3181878215465,
                1707454800
            ],
            [
                60.4810458419719,
                1707714000
            ],
            [
                60.1067941334562,
                1707800400
            ],
            [
                60.7272640712585,
                1707886800
            ],
            [
                61.8894141134915,
                1707973200
            ],
            [
                63.2977823850111,
                1708059600
            ],
            [
                64.056134531214,
                1708405200
            ],
            [
                64.1053781770713,
                1708491600
            ],
            [
                64.13,
                1708578000
            ],
            [
                65.83,
                1708664400
            ],
            [
                65.93,
                1708923600
            ],
            [
                66.33,
                1709010000
            ],
            [
                65.35,
                1709096400
            ],
            [
                64.16,
                1709182800
            ],
            [
                64.6,
                1709269200
            ],
            [
                64.79,
                1709528400
            ],
            [
                64.81,
                1709614800
            ],
            [
                65.27,
                1709701200
            ],
            [
                66.19,
                1709787600
            ],
            [
                66.5,
                1709874000
            ],
            [
                67.67,
                1710129600
            ],
            [
                67.4,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 9513,
        "drug_name": "CYFENDUS (AV7909)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Anthrax Vaccine",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-07-21",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/EBS\/news\/147700",
        "note": "Approved July 21, 2023.",
        "company_entity_id": 123,
        "company_ticker": "EBS",
        "company_name": "Emergent Biosolutions Inc.",
        "company_price": "2.3300",
        "company_change": -0.47,
        "company_percent_change": -16.79,
        "company_optionable": 1,
        "company_number_of_shares": 52203433,
        "price_change_sparkline": [
            [
                1.67,
                1706677200
            ],
            [
                1.65,
                1706763600
            ],
            [
                1.62,
                1706850000
            ],
            [
                1.53,
                1707109200
            ],
            [
                1.56,
                1707195600
            ],
            [
                1.5,
                1707282000
            ],
            [
                1.68,
                1707368400
            ],
            [
                1.58,
                1707454800
            ],
            [
                1.8,
                1707714000
            ],
            [
                1.59,
                1707800400
            ],
            [
                1.69,
                1707886800
            ],
            [
                1.7,
                1707973200
            ],
            [
                1.56,
                1708059600
            ],
            [
                1.52,
                1708405200
            ],
            [
                2.71,
                1708491600
            ],
            [
                2.8,
                1708578000
            ],
            [
                2.74,
                1708664400
            ],
            [
                2.85,
                1708923600
            ],
            [
                3.3,
                1709010000
            ],
            [
                3.2,
                1709096400
            ],
            [
                3.23,
                1709182800
            ],
            [
                3.39,
                1709269200
            ],
            [
                3.17,
                1709528400
            ],
            [
                3.41,
                1709614800
            ],
            [
                3.26,
                1709701200
            ],
            [
                2.77,
                1709787600
            ],
            [
                2.69,
                1709874000
            ],
            [
                2.8,
                1710129600
            ],
            [
                2.335,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 4886,
        "drug_name": "YCANTH (cantharidin)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Molluscum contagiosum",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-07-21",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/VRCA\/news\/147842",
        "note": "Approved July 21, 2023.",
        "company_entity_id": 558,
        "company_ticker": "VRCA",
        "company_name": "Verrica Pharmaceuticals Inc.",
        "company_price": "5.2000",
        "company_change": -0.010000000000000009,
        "company_percent_change": -0.18999999999999995,
        "company_optionable": 1,
        "company_number_of_shares": 42418553,
        "price_change_sparkline": [
            [
                5.65,
                1706677200
            ],
            [
                5.75,
                1706763600
            ],
            [
                5.67,
                1706850000
            ],
            [
                5.24,
                1707109200
            ],
            [
                5.36,
                1707195600
            ],
            [
                5.17,
                1707282000
            ],
            [
                5.24,
                1707368400
            ],
            [
                5.51,
                1707454800
            ],
            [
                5.75,
                1707714000
            ],
            [
                5.17,
                1707800400
            ],
            [
                5.28,
                1707886800
            ],
            [
                5.56,
                1707973200
            ],
            [
                5.445,
                1708059600
            ],
            [
                5.19,
                1708405200
            ],
            [
                4.99,
                1708491600
            ],
            [
                5.11,
                1708578000
            ],
            [
                5.18,
                1708664400
            ],
            [
                5.4,
                1708923600
            ],
            [
                5.67,
                1709010000
            ],
            [
                5.72,
                1709096400
            ],
            [
                5.27,
                1709182800
            ],
            [
                5.55,
                1709269200
            ],
            [
                5.55,
                1709528400
            ],
            [
                5.14,
                1709614800
            ],
            [
                4.97,
                1709701200
            ],
            [
                4.86,
                1709787600
            ],
            [
                5.01,
                1709874000
            ],
            [
                5.21,
                1710129600
            ],
            [
                5.2,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 7799,
        "drug_name": "XDEMVY",
        "clinical_trial_id": "NCT04784091",
        "has_trial_insight_page": 1,
        "indication": "Demodex Blepharitis",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-07-25",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/TARS\/news\/148231",
        "note": "FDA approved on July 25, 2023.",
        "company_entity_id": 825,
        "company_ticker": "TARS",
        "company_name": "Tarsus Pharmaceuticals Inc.",
        "company_price": "30.6100",
        "company_change": 0.11,
        "company_percent_change": 0.36,
        "company_optionable": 1,
        "company_number_of_shares": 34218886,
        "price_change_sparkline": [
            [
                27.24,
                1706677200
            ],
            [
                28.92,
                1706763600
            ],
            [
                28.54,
                1706850000
            ],
            [
                28.25,
                1707109200
            ],
            [
                29.6,
                1707195600
            ],
            [
                29.72,
                1707282000
            ],
            [
                31.19,
                1707368400
            ],
            [
                31.15,
                1707454800
            ],
            [
                30.82,
                1707714000
            ],
            [
                29.65,
                1707800400
            ],
            [
                31.02,
                1707886800
            ],
            [
                31.55,
                1707973200
            ],
            [
                30.7,
                1708059600
            ],
            [
                30.42,
                1708405200
            ],
            [
                30.13,
                1708491600
            ],
            [
                31.54,
                1708578000
            ],
            [
                31.7,
                1708664400
            ],
            [
                33.16,
                1708923600
            ],
            [
                39.22,
                1709010000
            ],
            [
                37.87,
                1709096400
            ],
            [
                38.22,
                1709182800
            ],
            [
                36.95,
                1709269200
            ],
            [
                36.89,
                1709528400
            ],
            [
                35.77,
                1709614800
            ],
            [
                36.44,
                1709701200
            ],
            [
                35.5,
                1709787600
            ],
            [
                33.33,
                1709874000
            ],
            [
                30.5,
                1710129600
            ],
            [
                30.61,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 7799,
        "drug_name": "XDEMVY",
        "clinical_trial_id": "NCT04784091",
        "has_trial_insight_page": 1,
        "indication": "Demodex Blepharitis",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-07-25",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/TARS\/news\/148231",
        "note": "FDA approved on July 25, 2023.",
        "company_entity_id": 1022,
        "company_ticker": "LIAN",
        "company_name": "LianBio",
        "company_price": "4.9500",
        "company_change": 0.03,
        "company_percent_change": 0.61,
        "company_optionable": 0,
        "company_number_of_shares": 108062638,
        "price_change_sparkline": [
            [
                4.11,
                1706677200
            ],
            [
                4.18,
                1706763600
            ],
            [
                4.13,
                1706850000
            ],
            [
                4.12,
                1707109200
            ],
            [
                4.17,
                1707195600
            ],
            [
                4.1,
                1707282000
            ],
            [
                4.09,
                1707368400
            ],
            [
                4.14,
                1707454800
            ],
            [
                4.04,
                1707714000
            ],
            [
                4.8,
                1707800400
            ],
            [
                4.76,
                1707886800
            ],
            [
                4.78,
                1707973200
            ],
            [
                4.77,
                1708059600
            ],
            [
                4.79,
                1708405200
            ],
            [
                4.79,
                1708491600
            ],
            [
                4.79,
                1708578000
            ],
            [
                4.79,
                1708664400
            ],
            [
                4.81,
                1708923600
            ],
            [
                4.815,
                1709010000
            ],
            [
                4.82,
                1709096400
            ],
            [
                4.84,
                1709182800
            ],
            [
                4.88,
                1709269200
            ],
            [
                4.89,
                1709528400
            ],
            [
                4.92,
                1709614800
            ],
            [
                4.94,
                1709701200
            ],
            [
                4.9,
                1709787600
            ],
            [
                4.93,
                1709874000
            ],
            [
                4.92,
                1710129600
            ],
            [
                4.95,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 2584,
        "drug_name": "Pz-cel (prademagene zamikeracel) - (VIITAL)",
        "clinical_trial_id": "NCT04227106",
        "has_trial_insight_page": 1,
        "indication": "Recessive dystrophic epidermolysis bullosa (RDEB)",
        "label": "BLA Filing",
        "value": "blaFiling",
        "simplified_stage": "phase4",
        "stageid": 12,
        "stage_name": "BLA Filing",
        "date": "2023-07-28",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/ABEO\/news\/149275",
        "note": "BLA filing package completed,  noted July 28, 2023. FDA pre-BLA meeting in August 2023, and expected BLA submission on 3Q, 2023.",
        "company_entity_id": 2,
        "company_ticker": "ABEO",
        "company_name": "Abeona Therapeutics Inc.",
        "company_price": "8.1800",
        "company_change": 0.37,
        "company_percent_change": 4.74,
        "company_optionable": 1,
        "company_number_of_shares": 24773317,
        "price_change_sparkline": [
            [
                4.07,
                1706677200
            ],
            [
                4.3,
                1706763600
            ],
            [
                4.42,
                1706850000
            ],
            [
                4.29,
                1707109200
            ],
            [
                4.3,
                1707195600
            ],
            [
                4.9,
                1707282000
            ],
            [
                5.28,
                1707368400
            ],
            [
                6.2,
                1707454800
            ],
            [
                6.48,
                1707714000
            ],
            [
                6.31,
                1707800400
            ],
            [
                6.15,
                1707886800
            ],
            [
                6.49,
                1707973200
            ],
            [
                7.01,
                1708059600
            ],
            [
                6.74,
                1708405200
            ],
            [
                6.75,
                1708491600
            ],
            [
                6.7,
                1708578000
            ],
            [
                6.98,
                1708664400
            ],
            [
                7.54,
                1708923600
            ],
            [
                7.35,
                1709010000
            ],
            [
                6.9,
                1709096400
            ],
            [
                6.9,
                1709182800
            ],
            [
                7.81,
                1709269200
            ],
            [
                7.81,
                1709528400
            ],
            [
                8.46,
                1709614800
            ],
            [
                8.68,
                1709701200
            ],
            [
                8.25,
                1709787600
            ],
            [
                7.97,
                1709874000
            ],
            [
                7.81,
                1710129600
            ],
            [
                8.18,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 6877,
        "drug_name": "JEMPERLI (Dostarlimab) - (RUBY)",
        "clinical_trial_id": "NCT03981796",
        "has_trial_insight_page": 1,
        "indication": "Endometrial Cancer",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-07-31",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/ANAB\/news\/149599",
        "note": "FDA approved on July 31, 2023.  Ahead of PDUFA on Sept. 23, 2023.",
        "company_entity_id": 379,
        "company_ticker": "GSK",
        "company_name": "GSK plc American Depositary Shares (Each representing two)",
        "company_price": "43.2700",
        "company_change": 0.35,
        "company_percent_change": 0.82,
        "company_optionable": 1,
        "company_number_of_shares": 2058516719,
        "price_change_sparkline": [
            [
                39.0637603938206,
                1706677200
            ],
            [
                40.2424083367376,
                1706763600
            ],
            [
                40.3315497777986,
                1706850000
            ],
            [
                41.1734411655964,
                1707109200
            ],
            [
                41.3517240477183,
                1707195600
            ],
            [
                41.6191483709012,
                1707282000
            ],
            [
                41.4210562796546,
                1707368400
            ],
            [
                41.5101977207156,
                1707454800
            ],
            [
                40.67821093748,
                1707714000
            ],
            [
                40.9951582834745,
                1707800400
            ],
            [
                41.40124707053,
                1707886800
            ],
            [
                41.371533256843,
                1707973200
            ],
            [
                41.5399115344025,
                1708059600
            ],
            [
                41.6191483709012,
                1708405200
            ],
            [
                41.5399115344025,
                1708491600
            ],
            [
                42.16,
                1708578000
            ],
            [
                42.22,
                1708664400
            ],
            [
                42.34,
                1708923600
            ],
            [
                42.38,
                1709010000
            ],
            [
                42.34,
                1709096400
            ],
            [
                41.9,
                1709182800
            ],
            [
                42.03,
                1709269200
            ],
            [
                42.44,
                1709528400
            ],
            [
                42.6,
                1709614800
            ],
            [
                42.62,
                1709701200
            ],
            [
                43.58,
                1709787600
            ],
            [
                43.14,
                1709874000
            ],
            [
                42.92,
                1710129600
            ],
            [
                43.27,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 6877,
        "drug_name": "JEMPERLI (Dostarlimab) - (RUBY)",
        "clinical_trial_id": "NCT03981796",
        "has_trial_insight_page": 1,
        "indication": "Endometrial Cancer",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-07-31",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/ANAB\/news\/149599",
        "note": "FDA approved on July 31, 2023.  Ahead of PDUFA on Sept. 23, 2023.",
        "company_entity_id": 394,
        "company_ticker": "ANAB",
        "company_name": "AnaptysBio Inc.",
        "company_price": "26.0600",
        "company_change": 2.71,
        "company_percent_change": 11.61,
        "company_optionable": 1,
        "company_number_of_shares": 26575178,
        "price_change_sparkline": [
            [
                23.6,
                1706677200
            ],
            [
                24.25,
                1706763600
            ],
            [
                24.01,
                1706850000
            ],
            [
                24.07,
                1707109200
            ],
            [
                24.02,
                1707195600
            ],
            [
                23.51,
                1707282000
            ],
            [
                23.13,
                1707368400
            ],
            [
                23.01,
                1707454800
            ],
            [
                23.07,
                1707714000
            ],
            [
                22.01,
                1707800400
            ],
            [
                22.29,
                1707886800
            ],
            [
                22.76,
                1707973200
            ],
            [
                24.1,
                1708059600
            ],
            [
                23.83,
                1708405200
            ],
            [
                25.49,
                1708491600
            ],
            [
                25.28,
                1708578000
            ],
            [
                25.87,
                1708664400
            ],
            [
                26.46,
                1708923600
            ],
            [
                26.47,
                1709010000
            ],
            [
                25.81,
                1709096400
            ],
            [
                25.53,
                1709182800
            ],
            [
                25.45,
                1709269200
            ],
            [
                26.15,
                1709528400
            ],
            [
                25.33,
                1709614800
            ],
            [
                25.49,
                1709701200
            ],
            [
                24.63,
                1709787600
            ],
            [
                24.8,
                1709874000
            ],
            [
                23.35,
                1710129600
            ],
            [
                26.06,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 5251,
        "drug_name": "ERVEBO (V920)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Ebola",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-08-03",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/MRK\/news\/150554",
        "note": "Approval in children aged 12 months and older on August 3, 2023.",
        "company_entity_id": 383,
        "company_ticker": "MRK",
        "company_name": "Merck & Company Inc.",
        "company_price": "122.6600",
        "company_change": -0.10999999999999999,
        "company_percent_change": -0.08999999999999997,
        "company_optionable": 1,
        "company_number_of_shares": 2532643872,
        "price_change_sparkline": [
            [
                120.78,
                1706677200
            ],
            [
                126.38,
                1706763600
            ],
            [
                126.41,
                1706850000
            ],
            [
                126.18,
                1707109200
            ],
            [
                126.88,
                1707195600
            ],
            [
                127.47,
                1707282000
            ],
            [
                126.61,
                1707368400
            ],
            [
                125.45,
                1707454800
            ],
            [
                125.34,
                1707714000
            ],
            [
                125.43,
                1707800400
            ],
            [
                125.82,
                1707886800
            ],
            [
                126.54,
                1707973200
            ],
            [
                127.79,
                1708059600
            ],
            [
                127.37,
                1708405200
            ],
            [
                128.12,
                1708491600
            ],
            [
                129.26,
                1708578000
            ],
            [
                129.45,
                1708664400
            ],
            [
                128.84,
                1708923600
            ],
            [
                129.03,
                1709010000
            ],
            [
                128.19,
                1709096400
            ],
            [
                127.15,
                1709182800
            ],
            [
                126.96,
                1709269200
            ],
            [
                124.05,
                1709528400
            ],
            [
                122.83,
                1709614800
            ],
            [
                123.75,
                1709701200
            ],
            [
                123.99,
                1709787600
            ],
            [
                123.5,
                1709874000
            ],
            [
                122.77,
                1710129600
            ],
            [
                122.66,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 5251,
        "drug_name": "ERVEBO (V920)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Ebola",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-08-03",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/MRK\/news\/150554",
        "note": "Approval in children aged 12 months and older on August 3, 2023.",
        "company_entity_id": 762,
        "company_ticker": "LUMO",
        "company_name": "Lumos Pharma Inc.",
        "company_price": "3.0200",
        "company_change": -0.030000000000000027,
        "company_percent_change": -0.98,
        "company_optionable": 0,
        "company_number_of_shares": 8107121,
        "price_change_sparkline": [
            [
                2.82,
                1706677200
            ],
            [
                3.01,
                1706763600
            ],
            [
                2.99,
                1706850000
            ],
            [
                3.1,
                1707109200
            ],
            [
                3.01,
                1707195600
            ],
            [
                3.05,
                1707282000
            ],
            [
                3.03,
                1707368400
            ],
            [
                2.99,
                1707454800
            ],
            [
                3.15,
                1707714000
            ],
            [
                3.025,
                1707800400
            ],
            [
                3.05,
                1707886800
            ],
            [
                3.05,
                1707973200
            ],
            [
                2.96,
                1708059600
            ],
            [
                3.05,
                1708405200
            ],
            [
                2.955,
                1708491600
            ],
            [
                3.02,
                1708578000
            ],
            [
                3,
                1708664400
            ],
            [
                3.04,
                1708923600
            ],
            [
                3.04,
                1709010000
            ],
            [
                3.05,
                1709096400
            ],
            [
                3.05,
                1709182800
            ],
            [
                3,
                1709269200
            ],
            [
                3,
                1709528400
            ],
            [
                3.05,
                1709614800
            ],
            [
                3.01,
                1709701200
            ],
            [
                3.03,
                1709787600
            ],
            [
                3.04,
                1709874000
            ],
            [
                3.05,
                1710129600
            ],
            [
                3.02,
                1710216000
            ]
        ],
        "statuses": []
    }
]